The importance of non-transferrin bound iron in disorders of iron metabolism

被引:231
作者
Breuer, W [1 ]
Hershko, C [1 ]
Cabantchik, ZI [1 ]
机构
[1] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel
来源
TRANSFUSION SCIENCE | 2000年 / 23卷 / 03期
关键词
D O I
10.1016/S0955-3886(00)00087-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concept of non-transferrin bound iron (NTBI) was introduced 22 years ago by Hershko et al. (Brit. J. Haematol. 40 (1978) 255). It stemmed from a suspicion that, in iron overloaded patients, the large amounts of excess iron released into the circulation are likely to exceed the serum transferrin (Tf) iron-binding capacity (TIBC), leading to the appearance of various forms of iron not bound to Tf. In accordance with this assumption, NTBI was initially looked for and detected in patients with greater than or equal to 100% Tf-saturation. As techniques for its detection became more sophisticated and sensitive, NTBI was also found in conditions where Tf was not fully saturated, leading to a revision of the original view of NTBI as a simple spillover phenomenon. In this review, we will discuss some of the properties of NTBI, methods for its detection, its significance and potential value as an indicator for therapeutic regimens of iron chelation and supplementation. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 49 条
[31]   Chromatographic method for the determination of non transferrin-bound iron suitable for use on the plasma and bronchoalveolar lavage fluid of preterm babies [J].
Kime, R ;
Gibson, A ;
Yong, W ;
Hider, R ;
Powers, H .
CLINICAL SCIENCE, 1996, 91 (05) :633-638
[32]   REGULATING THE FATE OF MESSENGER-RNA - THE CONTROL OF CELLULAR IRON-METABOLISM [J].
KLAUSNER, RD ;
ROUAULT, TA ;
HARFORD, JB .
CELL, 1993, 72 (01) :19-28
[33]   NEW CONCEPTS OF IRON AND ALUMINUM CHELATION-THERAPY WITH ORAL L1 (DEFERIPRONE) AND OTHER CHELATORS - A REVIEW [J].
KONTOGHIORGHES, GJ .
ANALYST, 1995, 120 (03) :845-851
[34]   Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method [J].
Loréal, O ;
Gosriwatana, I ;
Guyader, D ;
Porter, J ;
Brissot, P ;
Hider, RC .
JOURNAL OF HEPATOLOGY, 2000, 32 (05) :727-733
[35]   INTERACTION OF SERUM-ALBUMIN WITH THE FE(III)-CITRATE COMPLEX [J].
LOVSTAD, RA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1993, 25 (07) :1015-1017
[36]   A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation [J].
McKie, AT ;
Marciani, P ;
Rolfs, A ;
Brennan, K ;
Wehr, K ;
Barrow, D ;
Miret, S ;
Bomford, A ;
Peters, TJ ;
Farzaneh, F ;
Hediger, MA ;
Hentze, MW ;
Simpson, RJ .
MOLECULAR CELL, 2000, 5 (02) :299-309
[37]   The iron hypothesis - Does iron cause atherosclerosis? [J].
Meyers, DG .
CLINICAL CARDIOLOGY, 1996, 19 (12) :925-929
[38]   Iron release from human monocytes after erythrophagocytosis in vitro: An investigation in normal subjects and hereditary hemochromatosis patients [J].
Moura, E ;
Noordermeer, MA ;
Verhoeven, N ;
Verheul, AFM ;
Marx, JJM .
BLOOD, 1998, 92 (07) :2511-2519
[39]   Antioxidant protection against iron toxicity: Plasma changes during cardiopulmonary bypass in neonates, infants, and children [J].
Mumby, S ;
Chaturvedi, R ;
Brierley, J ;
Lincoln, C ;
Petros, A ;
Redington, A ;
Gutteridge, JMC .
FREE RADICAL RESEARCH, 1999, 31 (02) :141-148
[40]   Iron overload in paediatrics undergoing cardiopulmonary bypass [J].
Mumby, S ;
Chaturvedi, RR ;
Brierley, J ;
Lincoln, C ;
Petros, A ;
Redington, AN ;
Gutteridge, JMC .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1500 (03) :342-348